formaldehyde has been researched along with Bile Duct Cancer in 6 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recently, genetic alterations including chromosome abnormalities have been studied as predictive factors and to aid planning for further treatment." | 1.72 | Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients. ( Ainthachot, S; Chamgramol, Y; Deenonpoe, R; Pairojkul, C; Sa-Ngiamwibool, P; Thanee, M; Watcharadetwittaya, S, 2022) |
| "Advanced cholangiocarcinoma has a poor prognosis." | 1.72 | Precision oncology for intrahepatic cholangiocarcinoma in clinical practice. ( Brockschmidt, A; Chang, DH; Dill, MT; Kazdal, D; Longerich, T; Luedde, T; Mehrabi, A; Naumann, P; Schirmacher, P; Springfeld, C; Stenzinger, A; Tomczak, A; Wagner, U, 2022) |
| "Distal cholangiocarcinoma is an aggressive malignancy with a dismal prognosis." | 1.56 | Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker. ( Andersson, B; Andersson, R; Byrling, J; Hu, D; Kristl, T; Marko-Varga, G; Pla, I; Sanchez, A; Sasor, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ainthachot, S | 1 |
| Sa-Ngiamwibool, P | 1 |
| Thanee, M | 1 |
| Watcharadetwittaya, S | 1 |
| Chamgramol, Y | 1 |
| Pairojkul, C | 1 |
| Deenonpoe, R | 1 |
| Tomczak, A | 1 |
| Springfeld, C | 1 |
| Dill, MT | 1 |
| Chang, DH | 1 |
| Kazdal, D | 1 |
| Wagner, U | 1 |
| Mehrabi, A | 1 |
| Brockschmidt, A | 1 |
| Luedde, T | 1 |
| Naumann, P | 1 |
| Stenzinger, A | 1 |
| Schirmacher, P | 1 |
| Longerich, T | 1 |
| Byrling, J | 1 |
| Kristl, T | 1 |
| Hu, D | 1 |
| Pla, I | 1 |
| Sanchez, A | 1 |
| Sasor, A | 1 |
| Andersson, R | 1 |
| Marko-Varga, G | 1 |
| Andersson, B | 1 |
| Kindblom, LG | 1 |
| Dalberg, K | 1 |
| Terada, T | 1 |
| Shimizu, K | 1 |
| Izumi, R | 1 |
| Nakanuma, Y | 1 |
| Suto, T | 1 |
| Sugai, T | 1 |
| Nakamura, S | 1 |
| Funato, O | 1 |
| Nitta, H | 1 |
| Sasaki, R | 1 |
| Kanno, S | 1 |
| Saito, K | 1 |
6 other studies available for formaldehyde and Bile Duct Cancer
| Article | Year |
|---|---|
Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Chromosome Aberrations; Formaldeh | 2022 |
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Class I Phosphatidylinositol 3-Ki | 2022 |
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cholangiocarcinoma; Formaldehyde; | 2020 |
Sarcoma botryoides of the extrahepatic bile ducts. A light- and electron microscopic study of a case.
Topics: Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Child, Preschool; Fatal Outcome; Fixatives; Formaldeh | 1980 |
Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
Topics: Antibodies, Monoclonal; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma; Cholangiocarcinoma | 1994 |
Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Bile Duct Neoplasms; Bile Ducts, Extrahepati | 1998 |